[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100367440":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":37,"collaborators":39,"id":50,"slug":7,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":7,"eligibilityCriteria":54,"healthyVolunteers":51,"sex":55,"minAge":7,"maxAge":7,"enrollmentInfo":56,"targetDuration":59,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":69,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Newcastle-upon-Tyne Hospitals NHS Trust","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Chiara Marini Bettolo","PRINCIPAL_INVESTIGATOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Julie Bohill","CONTACT","0044 191 241 8640","julie.bohill@newcastle.ac.uk",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Newcastle University","RECRUITING","Newcastle upon Tyne","Tyne and Wear","NE1 3BZ","United Kingdom",{"type":27,"coordinates":28},"Point",[29,30],-1.61396,54.97328,{"lat":30,"lon":29},[33,36],{"name":34,"role":15,"phone":16,"phoneExt":7,"email":35},"Jo Bullivant","joanne.bullivant@newcastle.ac.uk",{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":11,"investigatorFullName":10,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Professor Neurologist and Clinical Lead, John Walton Muscular Dystrophy Research Centre. Clinical Lead of the Highly Specialised Service for Rare Neuromuscular Diseases, and Honorary Clinical Research Associate at Newcastle University",[40,43,45,48],{"name":41,"class":42},"Myotubular Trust","UNKNOWN",{"name":44,"class":42},"Muscular Dystrophy UK",{"name":46,"class":47},"Astellas Gene Therapies","INDUSTRY",{"name":49,"class":47},"Astellas Pharma Inc","100367440",false,"NCT04064307","Myotubular and Centronuclear Myopathy Patient Registry","Inclusion Criteria:\n\n* Patients with a myotubular myopathy or centronuclear myopathy diagnosis, which has been confirmed via genetic testing or muscle biopsy.\n* Any carrier females of x-linked myotubular myopathy, especially if they have manifested myotubular myopathy type symptoms.\n* Any patient who is deceased, but who had a confirmed diagnosis.\n\nExclusion Criteria:\n\n\\- None","ALL",{"count":57,"type":58},500,"ESTIMATED","1 Year","OBSERVATIONAL","The Myotubular and Centronuclear Myopathy Patient Registry (also referred to as the 'MTM and CNM Registry') is an international, patient-reported database specific to these conditions.\n\nMore details and online registration are available at www.mtmcnmregistry.org.",[63,64,65,66,67,68],"Myotubular Myopathy","Myotubular Myopathy 1","Myotubular (Centronuclear) Myopathy","Centronuclear Myopathy","Centronuclear Myopathy, X-Linked","X-linked Myotubular Myopathy",[70,71,72,73,74],"Registry","Patient Registry","Myotubular","Centronuclear","Myopathy","2025-04-07",{"date":77,"type":78},"2025-04-09","ACTUAL",{"date":80,"type":78},"2013-03-26",{"date":82,"type":58},"2025-05",{"name":5,"class":6},1]